Skip to main content

Loading market data...

IRTC

iRhythm Holdings, Inc.

NASDAQ • United states

$113.60

-$0.25

(-0.22%)

Source: Yahoo Finance · Quote time Oct 21, 2026 15:42 GMT+0000

Management
Credibility
Score

iRhythm Holdings, Inc. (IRTC)

Unavailable

Quotes may be delayed

$3.74B

Market Cap

136,322

Volume

Unavailable

P/E Ratio

Unavailable

Div Yield

iRhythm Holdings, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 699 8TH STREET, San Francisco, CA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

14 Oct 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in iRhythm Technologies, Inc..

5 Oct 2026

iRhythm Technologies, Inc. reported Regulation FD disclosure

iRhythm Technologies, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

23 Sep 2026

iRhythm Technologies, Inc. reported Regulation FD disclosure

iRhythm Technologies, Inc. filed an 8-K covering Regulation FD disclosure.

14 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in iRhythm Technologies, Inc..

14 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in iRhythm Technologies, Inc..

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$246.68M

Total assets (USD)$1.09B

Total liabilities (USD)$907.44M

Shareholders' equity (USD)$185.98M

Long-term debt (USD)$34.95M

Debt due within a year (USD)$0

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$224.17M	−$2.54M	−$381,000	−$0.01	10-Q · 6 Aug 2026
Q1 2026	$199.39M	−$16.19M	−$13.93M	−$0.43	10-Q · 30 Apr 2026
Q4 2025	$208.89M	$2.29M	$5.13M	Unavailable	10-K · 19 Feb 2026
Q3 2025	$192.88M	−$8.43M	−$5.21M	−$0.16	10-Q · 30 Oct 2025
Q2 2025	$186.69M	−$18.71M	−$14.22M	−$0.44	10-Q · 31 Jul 2025
Q1 2025	$158.68M	−$32.56M	−$30.70M	−$0.97	10-Q · 1 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $173.36

52.6% upside potential

📈

Strong Buy

Unavailable

👍

Buy

14

⏸️

Hold

0

📉

Sell

0

14 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 15:48 UTC Targets range 150.00–196.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

2

Sep 2026

Wilson Daniel G.

Chief Financial Officer

Open-market sale

$121.83 per share

773 shares

10

Aug 2026

Blackford Quentin S.

Director, President and CEO

Open-market sale

$124.65 per share

26,859 shares

10

Aug 2026

Murphy Patrick Michael

CBO and CLO

Open-market sale

$124.65 per share

7,093 shares

10

Aug 2026

Patterson Chad

CHIEF COMM & PRODUCT OFFICER

Open-market sale

$124.65 per share

7,093 shares

10

Aug 2026

Shrishrimal Sumi

EVP, Chief Risk Officer

Open-market sale

$124.65 per share

5,372 shares

10

Aug 2026

Turakhia Minang

CHIEF MED/SCI OFCR EVP ADVTECH

Open-market sale

$124.65 per share

7,093 shares

7

Aug 2026

Blackford Quentin S.

Director, President and CEO

Grant or award

Unavailable per share

48,534 shares

7

Aug 2026

Murphy Patrick Michael

CBO and CLO

Grant or award

Unavailable per share

13,589 shares

7

Aug 2026

Patterson Chad

CHIEF COMM & PRODUCT OFFICER

Grant or award

Unavailable per share

13,589 shares

7

Aug 2026

Shrishrimal Sumi

EVP, Chief Risk Officer

Grant or award

Unavailable per share

9,706 shares

Top Shareholders

Vanguard Group Inc

3,310,519 shares

2.173% change

12/31/2025

Blackrock, Inc.

2,985,667 shares

8.906% change

6/30/2026

Rtw Investments, Lp

2,182,631 shares

30.814% change

6/30/2026

Vanguard Portfolio Management Llc

1,913,976 shares

6.547% change

6/30/2026

Artisan Partners Limited Partnership

1,660,307 shares

14.432% change

6/30/2026

Vanguard Capital Management Llc

1,463,211 shares

1.211% change

6/30/2026

Millennium Management Llc

1,406,454 shares

-12.535% change

6/30/2026

Fmr Llc

1,191,982 shares

-12.478% change

6/30/2026

Ubs Am, A Distinct Business Unit Of Ubs Asset Management Ame

944,517 shares

-9.827% change

6/30/2026

Geode Capital Management, Llc

881,899 shares

7.929% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 15:48 UTC· 14 hours ago

Research coverage and investment tools

iRhythm Holdings, Inc. (IRTC) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Medical/Dental Instruments). Its last price was US$113.60 on 21 Oct 2026. That is 12% of the way from its 52-week low of US$100.70 to its 52-week high of US$212.00. Its market capitalisation was US$3.74 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$224.17M	−$2.54M	−$381,000	−$0.01	72.8%	-1.1%	$37.52M	10-Q · 6 Aug 2026 (opens in a new tab)
Q1 2026	$199.39M	−$16.19M	−$13.93M	−$0.43	70.9%	-8.1%	−$33.08M	10-Q · 30 Apr 2026 (opens in a new tab)
Q4 2025	$208.89M	$2.29M	$5.13M	Unavailable	70.9%	1.1%	$14.49M	10-K · 19 Feb 2026 (opens in a new tab)
Q3 2025	$192.88M	−$8.43M	−$5.21M	−$0.16	71.1%	-4.4%	$20.05M	10-Q · 30 Oct 2025 (opens in a new tab)
Q2 2025	$186.69M	−$18.71M	−$14.22M	−$0.44	71.2%	-10.0%	$17.29M	10-Q · 31 Jul 2025 (opens in a new tab)
Q1 2025	$158.68M	−$32.56M	−$30.70M	−$0.97	68.8%	-20.5%	−$17.31M	10-Q · 1 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/6/2026	$0.58	−$0.01	+5,900.0%
Mar 2026	4/30/2026	−$0.35	−$0.56	+37.5%
Dec 2025	2/19/2026	$0.29	$0.02	+1,350.0%
Sep 2025	10/30/2025	−$0.06	−$0.36	+83.3%

Cash and equivalents: $246.68M
Total assets: $1.09B
Total liabilities: $907.44M
Shareholders' equity: $185.98M
Long-term debt: $34.95M
Debt due within a year: $0

SCHEDULE 13G/A · 14 Oct 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in iRhythm Technologies, Inc..
8-K · 5 Oct 2026

iRhythm Technologies, Inc. reported Regulation FD disclosure (opens in a new tab)

iRhythm Technologies, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 23 Sep 2026

iRhythm Technologies, Inc. reported Regulation FD disclosure (opens in a new tab)

iRhythm Technologies, Inc. filed an 8-K covering Regulation FD disclosure.
SCHEDULE 13G/A · 14 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in iRhythm Technologies, Inc..
SCHEDULE 13G · 14 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in iRhythm Technologies, Inc..

Insider	Date	Transaction	Shares	Average price	Filing
Wilson Daniel G. Chief Financial Officer	2 Sep 2026	Open-market sale (S)	−773	$121.83	Form 4 (opens in a new tab)
Blackford Quentin S. Director, President and CEO	10 Aug 2026	Open-market sale (S)	−26,859	$124.65	Form 4 (opens in a new tab)
Murphy Patrick Michael CBO and CLO	10 Aug 2026	Open-market sale (S)	−7,093	$124.65	Form 4 (opens in a new tab)
Patterson Chad CHIEF COMM & PRODUCT OFFICER	10 Aug 2026	Open-market sale (S)	−7,093	$124.65	Form 4 (opens in a new tab)
Shrishrimal Sumi EVP, Chief Risk Officer	10 Aug 2026	Open-market sale (S)	−5,372	$124.65	Form 4 (opens in a new tab)
Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH	10 Aug 2026	Open-market sale (S)	−7,093	$124.65	Form 4 (opens in a new tab)
Blackford Quentin S. Director, President and CEO	7 Aug 2026	Grant or award (A)	+48,534	—	Form 4 (opens in a new tab)
Murphy Patrick Michael CBO and CLO	7 Aug 2026	Grant or award (A)	+13,589	—	Form 4 (opens in a new tab)
Patterson Chad CHIEF COMM & PRODUCT OFFICER	7 Aug 2026	Grant or award (A)	+13,589	—	Form 4 (opens in a new tab)
Shrishrimal Sumi EVP, Chief Risk Officer	7 Aug 2026	Grant or award (A)	+9,706	—	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	3,310,519	2.173%
Blackrock, Inc.	6/30/2026	2,985,667	8.906%
Rtw Investments, Lp	6/30/2026	2,182,631	30.814%
Vanguard Portfolio Management Llc	6/30/2026	1,913,976	6.547%
Artisan Partners Limited Partnership	6/30/2026	1,660,307	14.432%
Vanguard Capital Management Llc	6/30/2026	1,463,211	1.211%
Millennium Management Llc	6/30/2026	1,406,454	-12.535%
Fmr Llc	6/30/2026	1,191,982	-12.478%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Ame	6/30/2026	944,517	-9.827%
Geode Capital Management, Llc	6/30/2026	881,899	7.929%

Previous close: 113.85 USD
Day range: 112.02 – 116.14 USD
52-week range: 100.70 – 212.00 USD
Volume: 136,322
Market cap: $3.74B
Average volume: 516,077
EPS (FY 2025, diluted): −1.39 USD
Shares outstanding: 32.96M
Beta (5Y monthly): 1.49

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 15:42 UTC· 14 hours ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:33 UTC· 57 seconds ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for IRTC yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.